Common Contracts

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS EXHIBIT MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL EXCLUSIVE LICENSE AGREEMENT (Activin E Target)

Exclusive License Agreement • April 22nd, 2025 • iBio, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Exclusive License Agreement
• Filed
  April 22nd, 2025
• Company
  iBio, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Exclusive License Agreement (Activin E Target) (together with all Exhibits attached hereto, this “Agreement”) is made effective as of April 21, 2025 (the “Effective Date”), by and between iBio, Inc., a corporation organized under the laws of the State of Delaware, located at 11750 Sorrento Valley Road, Suite 200, San Diego, California 92121 (“iBio”), and AstralBio, Inc., a corporation organized under the laws of Delaware, located at 867 Boylston Street, 5th Floor #1833, Boston, Massachusetts 02116 (“AstralBio”). iBio and AstralBio are referred to in this Agreement individually as a “Party” and collectively as the “Parties.” Capitalized terms used in this Agreement have the meanings assigned to them in Article 1 below or where otherwise defined in this Agreement.

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS EXHIBIT MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL EXCLUSIVE LICENSE AGREEMENT (Myostatin Target)

Exclusive License Agreement • January 2nd, 2025 • iBio, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Exclusive License Agreement
• Filed
  January 2nd, 2025
• Company
  iBio, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Exclusive License Agreement (Myostatin Target) (together with all Exhibits attached hereto, this “Agreement”) is made effective as of December 31, 2024 (the “Effective Date”), by and between iBio, Inc., a corporation organized under the laws of the State of Delaware, located at 11750 Sorrento Valley Road, Suite 200, San Diego, California 92121 (“iBio”), and AstralBio, Inc., a corporation organized under the laws of Delaware, located at 867 Boylston Street, 5th Floor #1833, Boston, Massachusetts 02116 (“AstralBio”). iBio and AstralBio are referred to in this Agreement individually as a “Party” and collectively as the “Parties.” Capitalized terms used in this Agreement have the meanings assigned to them in Article 1 below or where otherwise defined in this Agreement.